Searchable abstracts of presentations at key conferences in endocrinology

ea0029p692 | Diabetes | ICEECE2012

Therapy with analogous of glp 1 and basal insulin in patients with diabetes mellitus type 2. Our experience.

Perez Rodriguez J. , Morales Portillo C. , Garcia Garcia C. , Fernandez Pena I. , Hernando Jimenez V. , Serrano Olmedo I. , De la Cuesta Mayor C. , Sendon Perez

Objectives: Evaluate the impact of the therapy with GLP-1 analogues (exenatide) toguether with basal insulin in glycemic control and weight of patients with type 2 diabetes mellitus poorly controlled.Materials and methods: We analyzed 37 patients with type 2 diabetes with poor glycemic control and obesity, treatment with exenatide and basal insulin. As pre-treatment 56.7% of our patients were with basal insulin, 10.8% with insulin mixtures and 32.4% with...